Matthew McManus - President - Diag & Spatial Bio at BIO-TECHNE Corp

Insider Transactions and Holdings

Entity Type
Individual
Role
President - Diag & Spatial Bio
Issuer Symbol
TECH on Nasdaq
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Matthew McManus since 11 Feb 2025

Holdings reported by Matthew McManus for BIO-TECHNE Corp

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Stock Option (Right to Buy) 24,614 $1,447,549 $58.81 01 Feb 2026 Direct Common Stock 24,614
Performance Restricted Stock Units 19,243 $1,131,680 $58.81 01 Feb 2026 Direct Common Stock 19,243
Common Stock 7,691 $492,916 $64.09 01 Feb 2026 Direct
Performance Stock Option (Right to Buy) 7,951 $467,598 $58.81 01 Feb 2026 Direct Common Stock 7,951
Restricted Stock Units 4,620 $271,702 $58.81 01 Feb 2026 Direct Common Stock 4,620

Transactions reported by Matthew McManus for BIO-TECHNE Corp

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.